THE ROLE OF POLYMORPHISM IN THE CALSEQUESTRIN GENE IN THE DEVELOPMENT OF ATRIAL FIBRILLATION AND SICK SINUS SYNDROME
https://doi.org/10.29001/2073-8552-2017-32-1-50-54
Abstract
At present, special attention is given to studying the role of genetic factors in the development of cardiovascular diseases. Wide implementation of the genetic and cellular technologies in the future may contribute to solving the problem of prevention and treatment of cardiac arrhythmias. Ion transport systems in the cardiomyocytes play an important role in the regulation of homeostasis of myocardial cells. The literature describes polymorphic variants in the calsequestrin gene associated with arrhythmias, sudden cardiac death, and development of heart failure in patients with ischemic heart disease. Objective: The objective of the study was to analyze the role of polymorphism in the calsequestrin 1 gene in the development of atrial fibrillation (AF) and sick sinus syndrome (SSS). The study included 47 patients aged 67.0±15.4 years (38 men (80.8%)). Among these patients, 15 individuals (31.9%) had AF; 11 patients (23.4%) had SSS; and 21 patients (44.6%) had combination of these pathologies. These patients had coronary artery disease (n=27 (57.4%)), hypertension (n=10 (21.2%)), myocarditis (n=3 (6.4%)), and idiopathic heart rhythm disturbances (n=7 (14.9%)). Only 35 patients had C/C genotype and 12 patients had C/T genotype. The frequencies of the C and T alleles in patients with a combination of AF and SSS were 88% and 12%, respectively. The frequencies of the C and T alleles in AF group were 93% and 7%, respectively. The frequencies of the C and T alleles in SSS group were 77% and 23%, respectively. Conclusion. The findings showed no significant associations of AF and SSS with the polymorphisms in the calsequestrin gene.
About the Authors
E. A. Archakov
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Russian Federation
Russian Federation
R. E. Batalov
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Russian Federation
Russian Federation
S. V. Popov
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Russian Federation
Russian Federation
E. F. Muslimova
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Russian Federation
Russian Federation
A. V. Smorgon
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Russian Federation
Russian Federation
S. A. Afanasiev
Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Russian Federation
Russian Federation
References
1. January C.T., Wann L.S., Alpert J.S. et al. Guideline for the management of patients with atrial fibrillation // J. Am. Coll. Cardiol. – 2014. – Vol. 64, No. 21. – P. 2246–2280.
2. Turakhia M., Solomon M.D., Jhaveri M. et al. Burden, timing, and relationship of cardiovascular hospitalization to mortality among Medicare beneficiaries with newly diagnosed atrial fibrillation // Am. Heart J. – 2013. – Vol. 166, No. 3. – P. 573– 580.
3. Kirchhof P., Auricchio A., Bax J. et al. Outcome parameters for trials in atrial fibrillation: executive summary // Eur. Heart J. – 2007. – Vol. 28. – P. 2803–2817.
4. Lehnart S.E., Maier L.S., Hasenfuss G. Abnormalities of calcium metabolism and myocardial contractility depression in the failing heart // Heart Fail. Rev. – 2009. – Vol. 14. – P. 213–224.
5. Priori S.G., Allot E., Blomstrom-Lundqvist C. et al. Update of the guidelines on sudden cardiac death of the European Society of Cardiology // Eur. Heart J. – 2003. – Vol. 24. – P. 13–15.
6. Емельянчик Е.Ю., Анциферова Е.В., Чернова А.А. и др. Диагностика синдрома слабости синусового узла у детей // Вестн. аритмол. – 2010. – Т. 32, № 61. – С. 6–14.
7. Franzini-Armstrong C., Protasi F., Ramesh V. Shape, size, and distribution of Ca(2+) release units and couplons in skeletal and cardiac muscles // Biophys. J. – 1999. – No. 77. – P. 1528– 1539.
8. Heinzel F.R., MacQuaide N., Biesmans L., Sipido K. Dyssynchrony of Ca2+ release from the sarcoplasmic reticulum as subcellular mechanism of cardiac contractile dysfunction // J. Mol. Cell Cardiol. – 2011. – Vol. 50, No. 3. – P. 390–400.
9. Бокерия О.Л., Ахобеков А.А. Ионные каналы и их роль в развитии нарушений ритма сердца // Анн. аритмол. – 2014. – T. 11, № 3. – С. 277–284.
10. Refaat M.M., Aouizerat B.E., Pullinger C.R. Association of CASQ2 polymorphisms with sudden cardiac arrest and heart failure in patients with coronary artery disease // Heart Rhythm. – 2014. – Vol. 11. – P. 646–652.
11. Glukhov A.V., Kalyanasundaram A., Lou Q. et al. Calsequestrin 2 deletion causes sinoatrial node dysfunction and atrial arrhythmias associated with altered sarcoplasmic reticulum calcium cycling and degenerative fibrosis within the mouse atrial pacemaker complex // Eur. Heart J. – 2015 – Vol. 14, No. 36(11). – P. 686–697.
12. Gussak I., Antzelevitch C. Electrical diseases of the heart. Genetics, mechanisms, treatment, prevention. – London : Springer-Verlag, 2008. – P. 461–654, 705–719.
Review
For citations:
Archakov E.A., Batalov R.E., Popov S.V., Muslimova E.F., Smorgon A.V., Afanasiev S.A. THE ROLE OF POLYMORPHISM IN THE CALSEQUESTRIN GENE IN THE DEVELOPMENT OF ATRIAL FIBRILLATION AND SICK SINUS SYNDROME. Siberian Journal of Clinical and Experimental Medicine. 2017;32(1):50-54. (In Russ.) https://doi.org/10.29001/2073-8552-2017-32-1-50-54
Views:
333
.png)
Email this article 